Kwaku Temeng - 19 May 2021 Form 4 Insider Report for CORE LABORATORIES N V

Role: Director
Signature: /s/ Mark Elvig, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 19 May 2021
Net transactions value: $0
Form type: 4
Filing time: 19 May 2021, 17:07:05 UTC
Next filing: 04 Apr 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLB	Restricted Shares	Award	$0	+4,307		$0.000000	4,307	19 May 2021	Common Shares	4,307	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Shares were granted to Mr. Temeng upon his election to the Board of Supervisory Directors of Core Laboratories N.V., as part of the annual grant given to all non-executive directors on April 1, 2021, and will vest, without performance criteria, on April 1, 2022, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance.

Content

The Restricted Shares were granted to Mr. Temeng upon his election to the Board of Supervisory Directors of Core Laboratories N.V., as part of the annual grant given to all non-executive directors on April 1, 2021, and will vest, without performance criteria, on April 1, 2022, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance.